Month: November 2024

Glasgow-based Sports Firm ‘Floored’ by Requests To Supply Global Film And TV Productions

Glasgow-based Sports Firm ‘Floored’ by Requests To Supply Global Film And TV Productions

www.gym-flooring.com

A Glasgow-based sports flooring firm, Sprung Gym Flooring, has ‘hit the groundrunning’, having been asked to supply floors for the sets of three global movie and TV productions.

Producers of ‘Mr Loverman’, ‘Mutiny’ (starring Jason Stratham) and ‘The Woman in Cabin 10’, starring Keira Knightly, have all requested set flooring from the Glasgow business.

With Glasgow firmly established as a world centre for film production – with big-budget movies such as World War Z and Indiana Jones previously having been filmed in the City Centre – local businesses have boomed with requests for sets, costumes and people to play extras.

Sprung supplied a sprint track for Mutiny; rubber gym flooring rolls for The Woman in Cabin 10, and is set to supply tatami mats for Mr Loverman.

Offering commercial and home gym flooring as well as a multitude of sports mats, sports floors and tiles, as well as FIFA-approved outdoor artificial turf, the company also floors schools, nurseries and hotels. Its floors are installed at Manchester United’s training facilities as well as branhes of Soho House and the firm provided flooring for several venues at the last Commonwealth Games to be held in Glasgow.

Managing Director Richard McKay said: “Glasgow’s starring role as a production centre for the global film industry is exciting not just for the people of the City, who get to see their hometown portrayed in different guises on the big screen, but for local businesses, who can really benefit from the big productions that are filmed here.

“From supplying flooring for gyms to seeing our products as part of the sets for movies that will be seen around the world has been surreal but fascinating for our team, which is based in the Hillington area of the city.

“We hope to see a great many more big-name movies being filmed in Glasgow in the future, creating jobs and revenue for local businesses.”

Sprung Gym Flooring is based at 51 Watt Road, Hillington.

More info: www.gym-flooring.com

Media Contact
Company Name: Pressat
Contact Person: Alison Lancaster
Email: Send Email
Country: United Kingdom
Website: https://pressat.co.uk/

Level Sensor Market worth $7.64 Billion in 2029, at a CAGR of 6.5%

“Level Sensor Market”
The global Level Sensor Market in terms of revenue is estimated to be worth $5.56 billion in 2024 and is poised to reach $7.64 billion in 2029, growing at a CAGR of 6.5% during the forecast period.

The report “Level Sensor Market by Type (Magnetostrictive, Vibratory Probe, Hydrostatic, Magnetic & Mechanical Float, Pneumatic, Guided Wave, Ultrasonic, Microwave, Optical, Capacitance Level Sensors), Sensor Type (Contact, Non-contact) – Global Forecast to 2029” The global level sensors industry size is projected to reach USD 7.64 billion in 2029 from USD 5.56 billion in 2024, with a CAGR of 6.5%.

Level sensor market growth is mainly fueled by the increasing demand for accurate and reliable level measurements in several manufacturing-related industries, as well as oil and gas, chemicals, and food and beverages. In addition, the growing adoption of automation, and initiatives under Industry 4.0, accompanied by increased demand for improved process efficiency and safety, will further drive the demand for advanced-level sensing technologies. With the mounting focus on environmental monitoring and sustainability, industries are adopting advanced-level sensors for resource management and environmental compliance.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=926

Browse 160 market data Tables and 60 Figures spread through 285 Pages and in-depth TOC on “Level Sensor Industry”

View detailed Table of Content here – https://www.marketsandmarkets.com/Market-Reports/level-sensors-market-926.html

Contact level sensors are projected to maintain a significant CAGR in the global level sensor industry during the forecast period.

Contact level sensors is expected to account for a significant growth rate in the global level sensor industry during the entire forecast period. This is due to their efficiencies in many industrial applications. Such sensors operate by directly making contact with the liquid or solid to be measured, to achieve precise measurements of levels, leaks, and flow rates. Their reliability, cost-effectiveness, and ability to function well in challenging environments like high temperatures or pressures make them perfect fits for industries like oil & gas, water & wastewater, and chemicals. Even though non-contact alternatives are increasing in popularity, contact sensors are still preferred due to the proven track record of performance at achieving accurate and uninterrupted level monitoring in the application.

Magnetic and Mechanical Float level sensors are expected to capture a significant share in the global market during the forecast period.

Magnetic and mechanical float level sensors are expected to capture a significant share of the market during the forecast period. These sensors work on float principle, where the float rises or falls with the liquid level, thus triggering a magnetic or mechanical switch indicating the level. It is ideal for those water & wastewater, oil & gas, and chemical processing industrial applications where very accurate monitoring of level is necessary. Its rugged design and the ability to operate well under harsh environments also support continued demand in many diverse applications. The high growth rate of automation will also boost the need for such proven technologies.

Continuous level monitoring is projected to hold the largest share in the global level sensor industry during the forecast period.

During the forecast period, continuous level monitoring will maintain the largest share in the level sensor industry since it can offer real-time, accurate measurement of liquid or solid levels over a long range. In contrast to point level sensors, which report only at a specific threshold being achieved, continuous level sensors track the entire range of levels. Continuous level sensors are more useful where precise level maintenance is absolutely necessary like in applications involving chemical processing, water treatment, or food production. Their ability to provide real time updates increases operational efficiencies, reduces downtime, and supports automated systems that require constant feedback about the material level. With the rising adoption of automation and smart manufacturing, the demand for this solution is expected to increase dramatically and that would further cement its position as a critical segment of the level sensor industry.

Liquid level sensors are projected to capture the highest share in the global level sensor industry during the forecast period.

By application liquid level sensors are projected to capture the highest share of the level sensor industry. Liquid applications require precise monitoring of liquid levels for both safety and process efficiency reasons and to ensure compliance with regulatory procedures. For example, reliable liquid-level sensors enable consistent product quality in food production and ensure optimal levels of water inside a wastewater plant. Advancements in wireless communication and further integration with IoT have been adding to the development of liquid level monitoring. The demand for liquid-level sensors is likely to grow in the coming years, driven by increasing automation and real-time analytics.

The pharmaceuticals sector is expected to experience significant growth in the level sensor industry during the forecast period.

The pharmaceutical industry is expected to grow at a significant CAGR in the level sensor industry over the forecast period. There is an increasing demand for the measurement of levels during critical processes such as drug formulation, fluids, and chemical storage. Level sensors play an extremely significant role in the pharmaceutical environment to ensure safety and compliance with strict regulatory standards to ensure that the product is of high quality. Implementation of automation and in-line monitoring will highly contribute to increased operational efficiency and reduced risks of contamination, thus increasing the demand for higher-grade sensors. Also, pharmaceutical production will further benefit from IoT and smart manufacturing technologies through improvement in the growth of level sensors.

Asia Pacific to capture the highest share in the global level sensor industry during the forecast period.

The Asia-Pacific region is expected to lead the level sensors industry during the forecast period. The tremendous growth is catalyzed by rapid industrialization, positive influences in manufacturing activities, and on-ground adoption of automation technologies across various process industries. In this region, industries like automotive, pharmaceuticals, chemicals, and water & wastewater management have expanded levels of dependency on precise level monitoring to enhance operational efficiency and meet standards defined by regulations. Besides, smart manufacturing and the support of IoT will increase the adoption of level sensors. As industrial automation and infrastructure investment is picking up demand for level sensors, in Asia Pacific, is likely to be increase.

Major companies operating in the level sensors industry include ABB  (Switzerland), Emerson Electric Co. (US), AMETEK.Inc. (US), Siemens (Germany), and Honeywell International Inc. (US).

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/level-sensors-market-926.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Level Sensor Market worth $7.64 Billion in 2029, at a CAGR of 6.5%

The Dynamic Duo: Marcus Parks and CBD

Introduction to Marcus Parks and CBD

In the vibrant landscape of music and entertainment, few names shine as brightly as Marcus Parks and CBD. Together, they represent a fresh wave of creativity, innovation, and cultural fusion. While Marcus Parks, CEO of We Up Multimedia, champions a diverse range of artistic expressions, CBD, also known as Cool But Deadly, brings a unique blend of Caribbean rhythms to the hip-hop scene. Their partnership embodies the essence of modern music: authenticity, passion, and collaboration.

Marcus Parks: A Visionary Leader Early Life and Musical Roots

Born and raised in Pomona, California, Marcus Parks developed a profound love for music early on. Surrounded by a vibrant community filled with diverse musical influences, he drew inspiration from various genres, which helped shape his artistic vision. This early exposure ignited a fire within him, fueling his ambition to make a significant impact in the entertainment industry.

The Journey to We Up Multimedia

Driven by his passion, Marcus embarked on a journey that ultimately led to the establishment of We Up Multimedia. His vision was clear: create a dynamic platform that encompasses film, music, and animation. This vision allows for a rich tapestry of storytelling and artistic expression. After making his mark in the California music scene, Marcus relocated to Atlanta, Georgia, a city recognized as a hub for creativity and culture. Under his leadership, We Up Multimedia has blossomed into a multifaceted enterprise dedicated to pushing artistic boundaries.

Commitment to Talent Development

At We Up Multimedia, Marcus Parks has made it his mission to discover and nurture new talent. He firmly believes in the power of collaboration, striving to create opportunities for emerging artists, musicians, and filmmakers. His commitment to developing talent is evident in the way the company operates as a launchpad for creativity, fostering an environment where innovative ideas can flourish.

CBD: The Caribbean Sensation A Unique Sound and Heritage

CBD, or Cool But Deadly, is a Guyanese-American musician who stands out for his vibrant fusion of Caribbean rhythms and contemporary urban influences. Drawing deeply from his rich heritage, CBD crafts music that resonates with themes of identity, resilience, and empowerment. His background in the diverse musical traditions of Guyana infuses his tracks with a unique blend of genres, including hip-hop, reggae, and dancehall.

Music That Speaks

CBD’s lyrics often reflect personal experiences and social commentary, making his music relatable and impactful. This authenticity is a hallmark of his artistry and is one of the reasons why fans connect with his sound on such a profound level. By addressing themes that resonate with everyday life, CBD creates a musical experience that transcends cultural boundaries.

The Synergy Between Marcus Parks and CBD A Shared Vision

What sets Marcus Parks and CBD apart in the music industry is their shared vision for innovation and authenticity. While Marcus focuses on creating a platform for diverse artistic expressions, CBD brings his unique sound and cultural background to the forefront. Together, they create a powerful synergy that not only enhances their individual brands but also enriches the musical landscape.

Breaking Barriers

Their collaboration is a testament to the idea that music knows no boundaries. With Marcus’s expertise in talent development and CBD’s captivating sound, they are breaking barriers and reshaping the industry. This partnership is about more than just music; it’s about creating a movement that embraces diversity, creativity, and collaboration.

Conclusion: The Future Looks Bright

As we look ahead, the future for Marcus Parks and CBD appears incredibly promising. Their dedication to authenticity, innovation, and collaboration is paving the way for new possibilities in the music industry. Marcus continues to inspire a new generation of artists, while CBD remains a powerful voice in hip-hop, representing cultural richness and resilience.

In a world that often feels repetitive and formulaic, the partnership between Marcus Parks and CBD is a refreshing reminder that there’s always room for creativity and genuine expression. So, keep an ear out for what’s next from this dynamic duo. They’re not just making music; they’re creating a legacy.

Contact Information

For inquiries or collaborations, you can reach out to Marcus Parks at weupnowmmg@gmail.com or visit www.weupent.com

By embracing the strengths of each other, Marcus Parks and CBD are not only transforming their own careers but also influencing the broader music scene in ways we can’t yet fully imagine. Stay tuned; the journey is just beginning!

Media Contact
Company Name: We Up Multimedia
Contact Person: Marcus
Email: Send Email
Phone: 470-381-5970
Address:485 Buford Dr Suite 305
City: Lawrenceville
State: GA
Country: United States
Website: https://weupent.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Dynamic Duo: Marcus Parks and CBD

Relapsed/Refractory Acute Myeloid Leukemia Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

DelveInsight’s, “Relapsed/refractory acute myeloid leukemia (AML) Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the Relapsed/Refractory Acute Myeloid Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our latest breakthroughs in Relapsed/Refractory Acute Myeloid Leukemia Research. Learn more about our innovative pipeline today! @ Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook

 

Key Takeaways from the Relapsed/Refractory Acute Myeloid Leukemia Pipeline Report

  • In November 2024:- Roswell Park Cancer Institute- This phase I/Ib trial studies the side effects and best dose of talazoparib given together with gemtuzumab ozogamicin and to see how well they work in treating patients with CD33 positive acute myeloid leukemia that has come back (relapsed) or does not respond to treatment (refractory). Talazoparib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Gemtuzumab ozogamicin is a protein (antibody) combined with a chemotherapy drug which specifically targets acute myeloid leukemia cells expressing a marker (CD33). Adding talazoparib to the gemtuzumab ozogamicin therapy may lead to an increased effectiveness in treatment.
  • In October 2024:- Astellas Pharma- The purpose of this study is to determine the clinical benefit of ASP2215 therapy in participants with FMS-like tyrosine kinase (FLT3) mutated acute myeloid leukemia (AML) who are refractory to or have relapsed after first-line AML therapy as shown with overall survival (OS) compared to salvage chemotherapy, and to determine the efficacy of ASP2215 therapy as assessed by the rate of complete remission and complete remission with partial hematological recovery (CR/CRh) in these participants.
  • In October 2024:- Sanofi- An Open-label, First-in-human, Dose-escalation/Expansion Study of SAR443579 Administered as Single Agent by Intravenous Infusion in Adult and Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • In October 2024:- Apollo Therapeutics Ltd- A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-4098 Alone and/or in Combination With Azacitidine in Adults With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome/AML (MDS/AML) or Myelodysplastic Syndrome With Excess Blasts (MDS-EB)
  • In October 2024:- Ryvu Therapeutics SA- The goal of this study is to assess the safety, tolerability, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of RVU120 when administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed or refractory to prior therapy with venetoclax and a hypomethylating agent. The study consists of three parts. Part 1 aims to identify the doses of RVU120 and venetoclax that are considered to be safe and tolerated. Part 2 will assess the safety and efficacy of the doses selected. And Part 3 is a confirmatory cohort where patients will be treated at the same doses assessed in Part 2
  • DelveInsight’s Relapsed/Refractory Acute Myeloid Leukemia pipeline report depicts a robust space with 50+ active players working to develop 75+ pipeline therapies for Relapsed/Refractory Acute Myeloid Leukemia treatment.
  • The leading Relapsed/Refractory Acute Myeloid Leukemia Companies such as Ascentage Pharma, Cullinan Oncology, Kronos Bio, Maxinovel Pharmaceuticals, AB Science, CicloMed, Karyopharm Therapeutics, Antengene Corporation, GlycoMimetics, Servier, Novartis, ImmunoGen, and others.
  • Promising Relapsed/Refractory Acute Myeloid Leukemia Therapies such as UCART 123, FHD-286, AB8939, ONC201, Sarclisa, TCB008, Keytruda, Uproleselan, Crenolanib, and others.

 

Stay informed about the cutting-edge advancements in Relapsed/Refractory Acute Myeloid Leukemia Treatments. Download for updates and be a part of the revolution in care @ Relapsed/Refractory Acute Myeloid Leukemia Clinical Trials Assessment

 

Relapsed/Refractory Acute Myeloid Leukemia Emerging Drugs Profile

  • APG-2575: Ascentage Pharma

APG-2575 is a novel oral Bcl-2 selective small molecule inhibitor under development by Ascentage Pharma. It restores the programmed cell death mechanism (apoptosis) of tumor cells by selectively inhibiting Bcl-2 protein, thereby inducing tumor cell apoptosis. , to achieve the purpose of tumor treatment. APG-2575 is the first locally developed Bcl-2 selective inhibitor to enter clinical stage in China. APG-2575 has been granted orphan drug designation by the US FDA for five indications (Indications: refractory chronic lymphocytic leukemia CLL, multiple myeloma, Waldenström macroglobulinemia, acute myeloid leukemia, follicular lymphoma).

  • CLN 049: Cullinan Oncology

CLN-049 (Florentine) is a humanized bispecific T cell engaging antibody being developed for the treatment of acute myeloid leukemia (AML). CLN-049 is designed to simultaneously bind to FLT3 on targeted leukemic cells and to CD3 on T cells, triggering the T cells to kill the selected cancer cells via their intrinsic cytolytic mechanisms. FLT3 is expressed frequently on AML cells and leukemic blasts but minimally on healthy blood cells, unlike other tumor surface antigens identified in AML, such as CD33 and CD123. CLN-049 can mediate potent and specific lysis of AML cells in vitro and promotes enhanced survival of mice bearing AML tumors. A phase I clinical trial with CLN-049 is currently ongoing for the treatment of patients with relapsed/refractory AML or MDS.

  • Lanraplenib: Kronos Bio

Lanraplenib, is a next-generation SYK inhibitor that has previously been studied as a potential treatment for autoimmune diseases. In preclinical studies, Lanraplenib was shown to have anti-leukemic activity against NPM1-mutated and FLT3-mutated AML samples. Lanraplenib, is being developed for the treatment of patients with relapsed/refractory FLT3-mutated AML and patients newly diagnosed with NPM1-mutated and/orFLT3-mutated AML who are older than 75 years old or are not eligible for intensive induction chemotherapy.

 

Learn more about Relapsed/Refractory Acute Myeloid Leukemia Drugs opportunities in our groundbreaking Relapsed/Refractory Acute Myeloid Leukemia Research and development projects @ Relapsed/Refractory Acute Myeloid Leukemia Unmet Needs

 

Relapsed/refractory acute myeloid leukemia (AML) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

  • Intra-articular
  • Intraocular
  • Intrathecal
  • Intravenous
  • Ophthalmic
  • Oral
  • Parenteral
  • Subcutaneous
  • Topical
  • Transdermal

 

Relapsed/Refractory Acute Myeloid Leukemia Products have been categorized under various Molecule types such as

  • Oligonucleotide
  • Peptide
  • Small molecule

 

Discover the latest advancements in Relapsed/Refractory Acute Myeloid Leukemia Treatment by visiting our website. Stay informed about how we’re transforming the future of Oncology @ Relapsed/Refractory Acute Myeloid Leukemia Market Drivers and Barriers, and Future Perspectives

 

Relapsed/Refractory Acute Myeloid Leukemia Market Drivers

  • Rising incidence of Acute Myeloid Leukemia, advancements in pharmacology and molecular biology to promote drug development, rising geriatric population are some of the important
  • factors that are fueling the Relapsed/Refractory Acute Myeloid Leukemia Market.

 

Relapsed/Refractory Acute Myeloid Leukemia Market Barriers

  • However, high cost associated with the management of AML, side effects associated with the AML treatment and other factors are creating obstacles in the Relapsed/Refractory Acute Myeloid Leukemia Market growth.

 

Scope of the Relapsed/Refractory Acute Myeloid Leukemia Pipeline Report

  • Coverage- Global
  • Relapsed/Refractory Acute Myeloid Leukemia Companies- Ascentage Pharma, Cullinan Oncology, Kronos Bio, Maxinovel Pharmaceuticals, AB Science, CicloMed, Karyopharm Therapeutics, Antengene Corporation, GlycoMimetics, Servier, Novartis, ImmunoGen, and others.
  • Relapsed/Refractory Acute Myeloid Leukemia Therapies- UCART 123, FHD-286, AB8939, ONC201, Sarclisa, TCB008, Keytruda, Uproleselan, Crenolanib, and others.
  • Relapsed/Refractory Acute Myeloid Leukemia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Relapsed/Refractory Acute Myeloid Leukemia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Relapsed/Refractory Acute Myeloid Leukemia Pipeline on our website @ Relapsed/Refractory Acute Myeloid Leukemia Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Relapsed/refractory acute myeloid leukemia (AML): Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Relapsed/refractory acute myeloid leukemia (AML)– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Drug name : Company name
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase I/II)
  11. APG-2575: Ascentage Pharma
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. CLN 049: Cullinan Oncology
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name : Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Relapsed/refractory acute myeloid leukemia (AML) Key Companies
  21. Relapsed/refractory acute myeloid leukemia (AML) Key Products
  22. Relapsed/refractory acute myeloid leukemia (AML)- Unmet Needs
  23. Relapsed/refractory acute myeloid leukemia (AML)- Market Drivers and Barriers
  24. Relapsed/refractory acute myeloid leukemia (AML)- Future Perspectives and Conclusion
  25. Relapsed/refractory acute myeloid leukemia (AML) Analyst Views
  26. Relapsed/refractory acute myeloid leukemia (AML) Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Relapsed/Refractory Acute Myeloid Leukemia Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

DDoS Protection & Mitigation Security Market Future Scope (Trending), Advance Technology, Growing Trends, Outlook, Global Size, Share And Forecast – 2029

“NetScout (US), Akamai (US), Radware (Israel), Huawei (China), Fortinet (US), Imperva (US), F5 (US), Cloudflare (US), BT (England), A10 Networks (US), Link11 (Germany), Fastly (US), Corero (UK), AIIoT (Israel), Stratacore (US), Sucuri (US).”
DDoS Protection & Mitigation Security Market by Solution Type (Network Traffic Analyzers, Threat Mitigation System, Botnet Detection & Management, Security Information & Event Management, Anomaly Detection, Orchestration & Automation) – Global Forecast to 2029.

The global market for DDoS protection and mitigation is expected to grow from USD 5.17 billion in 2024 to USD 9.63 billion by 2029, reflecting a Compound Annual Growth Rate (CAGR) of 13.2% over this period. As businesses become increasingly reliant on the internet, DDoS attacks have grown more frequent and sophisticated. The rise in IoT device usage has contributed to this trend, as many IoT devices lack robust security and can be hijacked by botnets to initiate DDoS attacks. Additionally, the transition from traditional infrastructures to cloud environments is driving demand for scalable DDoS protection solutions. Emerging regulatory and data protection requirements also compel organizations to strengthen defenses against DDoS and other cyber threats.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111952874  

Based on services, the professional services segment holds the largest market size during the forecast period.

Professionals, specialists, or experts offer professional services to support businesses. Professional services support businesses of all sizes and apply to all verticals. These include design and implementation, consulting and advisory, training and education, and support and maintenance. The latest techniques, strategies, and skills professionals adopt help organizations adopt DDoS protection and mitigation features. They also offer customized implementation and risk assessment and assist in deploying DDoS protection and mitigation security solutions via industry-defined best practices. The professionals provide solutions and support business goals with better communication services. Professional services help organizations stay protected from advanced threats.

Based on services, the managed services are projected to register the highest CAGR during the forecast period.

Managed Security Services (MSS) help provide network assessment, targeted scanning and reporting, unlimited report generation, security controls and remediation, vulnerability analysis, and live monitoring. Managed services is an approach that helps organizations outsource their IT operations, depending on their business requirements. The rising cyberattacks and ever-changing threat landscape lead to illegitimate traffic, forcing organizations to upgrade their IT infrastructures. Managed services help customers protect themselves from DDoS attacks and focus better on their core businesses. Managed services provide DDoS protection through the cloud, on-premises, and hybrid deployments. Managed service providers perform DDoS protection and mitigation for customers who do not possess the capabilities to detect and mitigate threats. Managed services protect online businesses and corporate data, monitor network traffic proactively, and detect and mitigate DDoS attacks and internet traffic abnormalities.

Based on region, North America holds the largest market size during the forecast period.

North America is expected to have the largest DDoS protection and mitigation security market size. Organizations in the region, especially in the US, have leveraged the benefits of Al, ML, and deep learning technologies to stay ahead in the market. North American countries have well-established economies, which enable DDoS protection and mitigation security vendors to invest in new technologies. Furthermore, the region is regarded as the center of innovation because the major North American IT companies roll out new offerings, and aggressive collaborations are done. The rapid penetration of mobile devices, such as smartphones, laptops, and USBs, and the imperative need to secure data residing within companies and being transferred over business networks are driving the adoption of DDoS protection and mitigation solutions in North America.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=111952874  

Unique Features in the DDoS Protection & Mitigation Security Market

Modern DDoS protection solutions are leveraging advanced threat intelligence and machine learning algorithms to detect and mitigate attacks in real time. These technologies enable systems to recognize unusual traffic patterns, identify potential threats, and deploy countermeasures before attacks can disrupt services.

With the shift to cloud and hybrid infrastructures, there is a rising demand for DDoS protection that can scale dynamically with network demands. Solutions today are designed with elasticity in mind, allowing businesses to expand or contract their security coverage as needed.

DDoS mitigation strategies are evolving from single-layer defenses to multi-layered approaches that provide comprehensive protection. These include network-layer defenses, application-layer filtering, and even DNS protection, creating multiple barriers that stop attacks at different levels.

Automation plays a significant role in modern DDoS protection, reducing response times and minimizing the need for manual intervention. By incorporating Security Orchestration, Automation, and Response (SOAR) capabilities, many solutions can automatically detect, analyze, and respond to threats.

As IoT devices and edge computing become more common, DDoS protection solutions are integrating features to safeguard these endpoints. Since many IoT devices lack built-in security, they are often vulnerable to exploitation by botnets.

Major Highlights of the DDoS Protection & Mitigation Security Market

The DDoS protection and mitigation market is experiencing substantial growth, driven by the increasing frequency and complexity of DDoS attacks. With global enterprises and small businesses alike facing growing cybersecurity risks, investments in DDoS protection have surged.

As more organizations migrate their operations to cloud environments, the demand for cloud-native DDoS protection solutions is rising. These cloud-based solutions offer flexible, scalable protection, enabling businesses to defend against high-volume attacks without requiring on-premise infrastructure.

Artificial intelligence (AI) and machine learning (ML) are transforming DDoS protection by enabling faster, more accurate threat detection and response. These technologies can analyze massive volumes of data in real time, detecting anomalies and preemptively blocking potential threats.

The rapid growth of IoT and edge devices has expanded the attack surface for DDoS threats. Many IoT devices lack robust security, making them prime targets for botnets.

Tightening regulatory and compliance standards, especially around data protection and cybersecurity, are driving organizations to adopt stronger DDoS defenses. With regulations like GDPR and CCPA requiring proactive security measures, DDoS protection has become a compliance priority.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=111952874  

Top Companies in the DDoS Protection & Mitigation Security Market

The major vendors in the DDoS protection & mitigation security market include NetScout (US), Akamai (US), Radware (Israel), Huawei (China), Fortinet (US), Imperva (US), F5 (US), Cloudflare (US), BT (England), A10 Networks (US). The market players have adopted various strategies such as developing advanced products, partnerships, contracts, expansions, and acquisitions to strengthen their DDoS protection & mitigation security market position. Organic and inorganic strategies have helped the market players expand globally by providing DDoS protection & mitigation security solutions.

NetScout

NetScout is a recognized application and network performance management solutions and products company. The product offerings include business assurance, service assurance, and security assurance, with strong DDoS attack and threat solutions and Business Intelligent solutions. NetScout specializes in serving customers from different industries, such as government, retail banking, healthcare and pharma, utilities, manufacturing, BFSI, education, and transportation. Arbor Networks is a security division of NetScout and offers the highest level of DDoS protection and mitigation services. It has many different DDoS protection and mitigation products some of which include Arbor Networks APS, Arbor Cloud, and Arbor Networks TMS. Arbor Networks APS is an on-premises tool that assists in the decryption and analysis of encrypted traffic.

Akamai

Akamai provides solutions in categories such as security solutions, web performance solutions, media delivery solutions, and network operator solutions. Akamai is into web and mobile acceleration, domain name systems and traffic management, media delivery, cloud security, and CDN. Its cloud security suite includes protection for application layers, bot management, DoS protection, and threat protection. The company is a global and prominent specialist in the market for DDoS protection and mitigation. The essential security solutions that Akamai put forward to counter DDoS are as follows:- Kona Site Defender, Web Application Protector, Fast DNS, Prolexic Kona Site Defender offers a naked shield to websites and applications against sophisticated DDoS attacks. The company enables enterprises to manage their network and infrastructures, save money, and have more throughputs over time. Akamai offers security solutions for websites, applications, and users to assist enterprises in managing constantly emerging threats.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ddos-protection-mitigation-market-111952874.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: DDoS Protection & Mitigation Security Market Future Scope (Trending), Advance Technology, Growing Trends, Outlook, Global Size, Share And Forecast – 2029

Firetog & Co. Rebrand & Release New Single “What You’re Good For”

Firetog & Co. Rebrand & Release New Single "What You’re Good For"

Show Flyer – Firetog & Co.
A Bold Chapter in Sound and Storytelling – Celebrated with a Release Show at Mr. Beery’s

Long Island, NY – Firetog & Co., formerly known as the Phil Firetog Trio & Co., embraces a new identity with the release of their genre-bending single, “What You’re Good For,” out today, November 8, 2024. This captivating track serves as an anthem for anyone who has faced the intoxicating cycles of toxic love. With powerful lyrics and immersive instrumentals, “What You’re Good For” dives deep into the emotional games that define many modern relationships. Firetog & Co. brings their new release to life tonight at Mr. Beery’s in Bethpage, NY at 10 p.m., with special performances by Good Vibes, Anything Ever, and Don Moon.

Recorded at Vudu Studios in Port Jefferson, NY, “What You’re Good For” combines folk storytelling with the raw edge of alternative indie. The song is a sonic journey, moving from soft, introspective moments to powerful crescendos that reflect the emotional highs and lows of a toxic relationship. Lines like “You want your song – But you’re not good for me” capture the turmoil between longing and self-worth. Self-produced by the band and mixed and mastered by Mike Watts and Frank Mitaritonna, the track is a deeply cinematic experience that resonates with listeners navigating complex relationships.

“What You’re Good For is for anyone who’s had to balance between desire and knowing their worth,” says Phil Firetog. “We wanted this track to capture the intense pull of a relationship that isn’t healthy but is undeniably hard to leave.”

“What You’re Good For” isn’t just a single release — it marks the beginning of a new chapter for the band, embracing a deeper collaboration. Formerly known as Phil Firetog Trio & Co., the band has rebranded as Firetog & Co., reflecting a shift from a traditional trio to a collaborative collective. Founded by Phil Firetog (vocals/guitar), Liam Gordon (bass), and Johnny “Pots” Potoncik (drums), the group now includes Tye Granger (saxophone), Brandon Rivas (trumpet/trombone), Dustin Bartley (violin/cello), and Alex Kamm (piano/organ), each bringing unique musical influences that have expanded their sound.

To celebrate “What You’re Good For,” Firetog & Co. will perform a live show tonight at Mr. Beery’s, joined by Good Vibes, Anything Ever, and Don Moon. Known for their immersive, unpredictable performances, Firetog & Co. promises an evening of dynamic music. Fans can also look forward to a live acoustic music video for “What You’re Good For,” premiering November 15, 2024. Filmed at Vudu Studios, the video offers an intimate take on the song with core band members and guest musicians.

“What You’re Good For” will be available on all major streaming platforms, including Spotify and Apple Music. To stay updated on Firetog & Co., follow them on social media: Instagram, Facebook, and YouTube.

Media Contact
Company Name: Firetog & Co.
Contact Person: Phil Firetog
Email: Send Email
Country: United States
Website: https://firetog.music

Digital Education Market Growth (Latest), Recent Development, Opportunities Business Scenario, Share, Size, Scope, Key Segments And Forecast To 2028

“Coursera (US), edX (US), Pluralsight (US), Udemy (US), Udacity (US), Edureka (India), Alison (Ireland), LinkedIn Learning (US), Jigsaw Academy (India), Iversity (Germany), Miriadax (Spain), Intellipaat (India), FutureLearn (UK), Edmodo (US), SWAYAM (India), Novoed (US), Xuetangx (China).”
Digital Education Market by Type (Self-paced Online Education and Instructor-led Online Education), Course Type, End User (Academic Institutions and Enterprises & Public Sector) and Region – Global Forecast to 2028.

The global Digital Education Market is projected to expand from USD 11.5 billion in 2021 to USD 46.7 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 32.3% over the forecast period. Key drivers of this growth include increased internet penetration, reduced infrastructure costs, enhanced scalability through online learning, and the demand for microlearning. Additionally, digital education offers greater efficiency, convenience, and flexibility, making it increasingly popular across various sectors.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7751828  

By End Users, government and public sector segment to record significant growth during the forecast period

Enterprises are majorly adopting digital education as a part of their employee engagement and development programs. These companies implement digital education platforms for various purposes, such as training and development, professional certification, and professional courses, to develop their employee’s strategic thinking abilities and improve the company’s production and brand value. Digital education courses act as a cost-effective learning platform to enhance employees’ skills and enable organizations to track their employees’ progress. An organization can opt for tailor-made courses which accomplish the company’s objectives. Digital education also provides the necessary flexibility to train employees without compromising productivity. Online learning approaches, such as microlearning and nanodegrees, provide employees with the skills needed without consuming much of their time.

By Type, the Self-paced Online Education segment to exhibit significant growth during the forecast period

Between the Type, the Self-paced Online Education segment courses do not follow a set schedule. Hence, all the learning resources are readily available, allowing end users to absorb and retain information faster than in a classroom setting. Self-paced online courses do not require instructors and students to be available simultaneously during the entire course. Instructors can record videos or provide content that students can learn without the instructor’s involvement. Unlike self-paced digital education courses, instructor-led digital education courses follow a particular set of schedules with a specified time for the availability of learning resources. More and more educational institutes and companies are using self-paced online education to provide their students and employees with constant access to information. This also provides learners with complete control of their progress.

By region, North America to account for the highest market share during the forecast period

North America has an advanced communication infrastructure that helps digital education solution providers offer quality services to their clients. The need to upskill employees and students has prompted universities and educational organizations in the region to deploy digital education platforms and services. In the education sector, owing to the advanced technologies offered by several key vendors present in the region, students are more digitally connected and aware of eLearning and interactive course content. Even teachers and parents are sensing the need to shift from traditional teaching methodologies to modern and advanced teaching methods to improve the learning experience and educational technology. The region is also one of the earliest adopters of 5G technology, which has helped the early adoption of digital education solutions. Countries such as US and Canada are expected to be key revenue contributors in the North American digital education market. North America is home to most crucial market vendors, such as Coursera, edX, Udacity, and Udemy, in the digital education market.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=7751828  

Unique Features in the Digital Education Market

Digital education platforms are increasingly using AI to provide personalized learning experiences that adapt to each student’s unique needs. Adaptive learning technologies analyze students’ progress, strengths, and areas for improvement, tailoring content to optimize learning outcomes.

The incorporation of interactive elements, such as gamification, augmented reality (AR), and virtual reality (VR), has transformed digital education. These tools make learning more engaging and hands-on, allowing students to experience practical scenarios virtually.

Microlearning is on the rise in digital education, offering content in short, focused segments that make learning more manageable. These bite-sized modules are ideal for learners with busy schedules or those seeking specific skill development.

Digital education platforms offer scalable solutions that allow institutions and organizations to expand their reach to a larger audience without incurring significant infrastructure costs. This scalability makes it feasible for schools, universities, and corporations to deliver consistent and high-quality education across diverse geographies, at a fraction of traditional costs.

With digital education, robust data analytics tools provide valuable insights into learner progress and engagement. These analytics help educators identify trends, track performance, and adjust content to improve learning outcomes.

Major Highlights of the Digital Education Market

The digital education market has seen significant expansion, with a strong growth trajectory driven by increased internet access and the rising demand for online learning solutions.

Mobile learning is a crucial component of digital education, allowing learners to access educational content from anywhere. With the widespread use of smartphones and tablets, mobile learning has made education more flexible and convenient, catering to learners on the go.

As industries prioritize skills over traditional degrees, digital education platforms are increasingly focused on providing specialized, skill-based courses and certification programs.

Artificial intelligence (AI) is transforming digital education by enabling adaptive and personalized learning experiences. AI analyzes learners’ behaviors, preferences, and performance data to tailor content, making education more effective and engaging.

Microlearning, which delivers content in concise, focused modules, is increasingly popular in digital education, particularly in professional and corporate training. This format allows learners to absorb information quickly and efficiently, fitting learning into busy schedules.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=7751828  

Top Companies in the Digital Education Market

Major vendors in the Digital Education Market include Coursera (US), edX (US), Pluralsight (US), Udemy (US), Udacity (US), Edureka (India), Alison (Ireland), LinkedIn Learning (US), Jigsaw Academy (India), Iversity (Germany), Miriadax (Spain), Intellipaat (India), FutureLearn (UK), Edmodo (US), SWAYAM (India), Novoed (US), Xuetangx (China), Khan Academy (US), Kadenze (US), Federica Web Learning (Italy), My Mooc (France), Treehouse (US), Skillshare (US), CreativeLive (US), CXL (US), Go1 (Australia), Byju’s (India), Datacamp (US), Platzi (US), Thinkful (US).

Coursera (US)

Coursera is a Massive Open Online Course (MOOC) provider that offers digital education solutions for businesses, universities, governments, and individuals. The company offers Certificates, MasterTrack Certificates, and Degrees to individual students and offers custom solutions for organizations. The company delivers courses to millions of users through recorded video lectures, auto-graded and peer-reviewed assignments, and community discussion forums. In September 2020, Coursera partnered with Facebook to launch a new Social Media Marketing Professional Certificate. This would help learners without a college degree or any prior experience to become ready for social media marketing jobs within a few months.

edX (US)

edX is a non-profit online learning platform and digital education provider focused on transforming online and classroom learning through distinct methodologies, game-like educational experiences, and cutting-edge research on open-source platforms. The platform offers a wide variety of courses in science, technology, humanities, and other domains. edX offers programs, such as microbachelors programs, bachelor’s degrees, micromasters programs, master’s degrees, and professional certificates. In September 2021, edX partnered with LinkedIn Learning. The integration of LinkedIn Learning Hub would enable customers of edX for Business to discover the right content in one place, easily access skills insights across content sources, and customize the learner experience with curated learning paths.

Pluralsight (US)

Pluralsight, founded in 2004 and based in Draper, Utah, is a technology-focused online learning platform that provides courses for IT professionals, developers, and creatives through a subscription model. It features skill assessments, guided learning paths, interactive labs, and certification preparation, catering to individual learners, businesses, and institutions.

Udemy (US)

Udemy, established in 2010 and headquartered in San Francisco, California, is a global online learning and teaching marketplace. It offers over 130,000 courses in various subjects created by individual instructors. Users benefit from lifetime access to purchased courses, certificates of completion, a mobile app, and an enterprise version called Udemy for Business for organizational training.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103
City: Delray Beach
State: FL 33445
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/digital-education-market-7751828.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Education Market Growth (Latest), Recent Development, Opportunities Business Scenario, Share, Size, Scope, Key Segments And Forecast To 2028

Lateral Flow Assay Market with Business Strategy, Key Drivers, Opportunities, Top Key Companies Analysis and Forecast

“The key players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US),and PerkinElmer Inc. (US).”
Browse 419 market data Tables and 59 Figures spread through 399 Pages and in-depth TOC on “Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User – Global Forecast to 2029

The Lateral Flow Assays industry is expected to grow significantly in the near future due to the increasing demand for rapid, portable, and easy-to-use diagnostic tests. Lateral flow assays have already proven to be valuable in a variety of applications, including medical diagnostics, food safety testing, environmental monitoring, and drug testing, among others. Advances in technology and the development of new and more sensitive detection methods are likely to further improve the performance and accuracy of lateral flow assays, making them even more versatile and useful in the years to come.

Lateral Flow Assays Market in terms of revenue was estimated to be worth $20.5 billion in 2022 and is poised to reach $22.6 billion by 2027, growing at a CAGR of 2.0% from 2022 to 2027 according to a new report by MarketsandMarkets™. The increasing demand of lateral flow assays due to increase in prevalence of infectious disease, increasing number of geriatric populations in many countries, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. On the other hand, reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key restraints.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133

Browse in-depth TOC on “Lateral Flow Assays Market”

366 – Tables

58 – Figures

374 – Pages

In this report, the lateral flow assays market is segmented on the basis of product type, application type, technique type, sample type, end user, and region.

“Lateral Flow Readers segment is expected to witness the fastest growth during the forecast period”

Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. During the forecast period, this segment is expected to witness the fastest growth during the forecast period. The factors responsible for the growth of this segment are increasing demand of quantitative analysis of clinical sample.

“Veterinary Diagnostics segment accounted for the second largest share of lateral flow assays market in 2021”

Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The veterinary diagnostics segment accounted for the second largest share of the lateral flow assays market in 2021. The possibility of infectious disease outbreaks (particularly in large livestock animals) is driving the demand for lateral flow tests due to their simplicity and rapidity compared to conventional detection methods.

“Multiplex Detection Assays technique is expected to witness the fastest growth during the forecast period”

Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The multiplex detection assays technique is expected to witness the fastest growth during the forecast period. The widening scope, applications, and research on multiplex detection assays are expected to boost the growth of this segment in the forecast period.

The lateral flow assays market is segmented into five regions namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Asia-Pacific is the second largest region along with fastest growing region of lateral flow assays market owing to major investments in rapid testing in this region.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=167205133

Lateral Flow Assays Market Dynamics:

Drivers:

  1. High prevalence of infectious diseases across the globe
  2. Rapidly increasing geriatric population
  3. Growing usage of home-based lateral flow assay devices
  4. Growing demand for point-of-care testing
  5. Need for rapid diagnostic testing for COVID-19

Restraints:

  1. Inconsistent results of lateral flow assay tests

Opportunities:

  1. Evolving applications of lateral flow assays
  2. Rising demand for lateral flow assays in the food & beverage industrya.  Omicron – The new variant of concern is an opportunity for the lateral flow assays marketb.  Government initiatives for omicronc.  Initiatives of Medical diagnostic companies for omicron

Challenges:

  1. Limited reimbursements for lateral flow assay products
  2. Difficulties in procuring quality raw materials for the development of lateral flow assay tests

Key Market Players:

The prominent players in the global lateral flow assays market include Abbott Laboratories (US), Quidel Corporation (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), and Merck KGaA (Germany).

Recent Developments:

  • In October 2022, F. Hoffmann-La Roche Ltd. (Switzerland) a next-generation portfolio of SARS-CoV-2 rapid antigen test 2.01, SARS-CoV-2 Rapid Antigen Test 2.0 Nasal2, and SARS-CoV-2 Rapid Antigen Test 2.0 Nasal3
  • In June 2021, Abbott Laboratories (US) received the CE approval for PanBio Rapid Antigen Self-test, opening access throughout Europe to fast, reliable COVID-19 testing

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133

Lateral Flow Assays Market – Report Highlights:

Refinements in the segments of the lateral flow assays market

The current edition of the report consists of an updated market overview. Additional points in the market overview have been added, keeping in mind the impact of COVID-19 on the overall lateral flow assays market and economic recession impact on lateral flow assays market. Also impact of economic recession on regional market size has been considered in this edition.

Coverage of new market players in the lateral flow assays market

The new edition of the report includes profiles for Oranoxis Inc. (US), AESKU. Diagnostics Gmbh (Germany), Bio Group Medical System (Italy), Pharmact Gmbh (Germany), DIESSE Diagnostica Senese S.P.A (Italy), and Xiamen Biotime Biotechnology Co., Ltd (China).

Updated financial information/product portfolio of players

The new edition of the report provides updated financial information until 2021 for each listed company in a graphical representation as a single diagram (instead of multiple tables). This will easily help analyze the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating country/region, business segment focus in terms of the highest revenue-generating segment, and R&D investments.

Updated market developments of profiled players

Recent developments are important to understand market trends and the growth strategies adopted by players. The current edition of this report provides updated developments of profiled players from January 2019 to December 2022, indicating a continuation from the previous version. Product/services launches, approvals, and upgrades, expansions, acquisitions, agreements, partnerships, and collaborations were the principal growth strategies adopted by market players in this period.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/lateral-flow-assay-market-167205133.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lateral Flow Assay Market with Business Strategy, Key Drivers, Opportunities, Top Key Companies Analysis and Forecast

Acute Ischemic Stroke Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

DelveInsight’s, “Acute Ischemic Stroke Pipeline Insight 2024” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Acute Ischemic Stroke pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore our latest breakthroughs in Acute Ischemic Stroke Research. Learn more about our innovative pipeline today! @ Acute Ischemic Stroke Pipeline Outlook

 

Key Takeaways from the Acute Ischemic Stroke Pipeline Report

  • In November 2024:- Shanghai Hutchison Pharmaceuticals Limited- This study is a Phase II, multicenter, randomized, double Blind, placebo-Controlled design. Participants receive twice daily dosing for 7 consecutive days, or once on Days 1 and Day 8 and twice daily on Days 2 to Day 7, with each subject scheduled to receive 14 doses throughout the clinical trial. 270 Participants will be randomized 1:1:1 to SHPL-49 injection treated group (3 ampoules of SHPL-49 injections, BID), SHPL-49 injection treated group (6 ampoules of SHPL-49 injections , BID) and placebo group (BID).
  • DelveInsight’s Acute Ischemic Stroke pipeline report depicts a robust space with 180+ active players working to develop 200+ pipeline therapies for Acute Ischemic Stroke treatment.
  • The leading Acute Ischemic Stroke Companies such as Tasly Pharmaceutical, Revalesio Corporation, Avilex Pharma, GNT Pharma, Biogen, AptaTargets, NC Medical Research, Prolong Pharmaceuticals, Saillant Therapeutics, TargED Biopharmaceuticals and others.
  • Promising Acute Ischemic Stroke therapies such as Sovateltide, Tenecteplase, BB-031, hUCB, LT3001, Elezanumab, Redasemtide, Cerebrolysin, SP-8203, and others.

 

Stay informed about the cutting-edge advancements in Acute Ischemic Stroke treatments. Download for updates and be a part of the revolution in care @ Acute Ischemic Stroke Clinical Trials Assessment

 

Acute Ischemic Stroke Emerging Drugs Profile

  • Prourokinase recombinant: Tasly Pharmaceutical

Prourokinase recombinant, is an investigational drug being developed by Tasly Pharmaceutical for the treatment of Acute Ischemic Stroke. Recombinant human (rh) Pro-UK, is a novel type of thrombolytic, which preferentially activates plasminogen on the fibrin surface and induces fibrin-selective clot lysis. It has the advantages of more potent efficacy and less adverse reactions in comparison with other thrombolytics. Advantages of thrombolytic therapy using rhPro-UK for patients with acute myocardial infarction include its reliable curative effect and high safety. Currently, the drug is in the Phase III stage of its development for the treatment of Acute Ischemic Stroke.

  • RNS60: Revalesio Corporation

RNS60 is being developed to provide disease modifying and potentially restorative treatments for neurological diseases. It activates intracellular signaling pathways to increase mitochondrial biogenesis and function and reduce inflammation. RNS60 safely protects neurons and oligodendrocytes and modulates the activity of immune cells to restore homeostasis. RNS60 has been granted Orphan Drug and Fast Track designations for ALS from the U.S. Food and Drug Administration. Currently, the drug is in the Phase II stage of its development for the treatment of Acute Ischemic Stroke.

  • AVLX 144: Avilex Pharma

AVLX-144 is a dimeric peptide-like drug candidate for the treatment of AIS, which targets the intracellular scaffolding protein, PSD-95. AVLX-144 is an extensively optimized dimeric PSD-95 inhibitor and a clinical lead candidate for the treatment of acute conditions such as AIS and subarachnoid hemorrhage (SAH). PSD-95 bridges the glutamate receptor subtype – the N-methyl-D-aspartate (NMDA) receptor and neuronal nitric oxide synthase (nNOS) via its two PDZ domains and AVLX-144 binds to both these PDZ domains simultaneously. The specific design of AVLX-144 provides several key advantages such as exceptionally high affinity to PSD-95, increased stability, and enhanced neuroprotective properties. Currently, the drug is in the Phase I stage of its development for the treatment of Acute Ischemic Stroke.

 

Learn more about Acute Ischemic Stroke Drugs opportunities in our groundbreaking Acute Ischemic Stroke Research and development projects @ Acute Ischemic Stroke Unmet Needs

 

Acute Ischemic Stroke Companies

Tasly Pharmaceutical, Revalesio Corporation, Avilex Pharma, GNT Pharma, Biogen, AptaTargets, NC Medical Research, Prolong Pharmaceuticals, Saillant Therapeutics, TargED Biopharmaceuticals and others

 

Acute Ischemic Stroke pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Acute Ischemic Stroke Products have been categorized under various ROAs such as

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

 

Acute Ischemic Stroke Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

 

Discover the latest advancements in Acute Ischemic Stroke treatment by visiting our website. Stay informed about how we’re transforming the future of disease @ Acute Ischemic Stroke Market Drivers and Barriers, and Future Perspectives

 

Scope of the Acute Ischemic Stroke Pipeline Report

  • Coverage- Global
  • Acute Ischemic Stroke Companies such as Tasly Pharmaceutical, Revalesio Corporation, Avilex Pharma, GNT Pharma, Biogen, AptaTargets, NC Medical Research, Prolong Pharmaceuticals, Saillant Therapeutics, TargED Biopharmaceuticals and others.
  • Acute Ischemic Stroke Therapies- Sovateltide, Tenecteplase, BB-031, hUCB, LT3001, Elezanumab, Redasemtide, Cerebrolysin, SP-8203, and others.
  • Acute Ischemic Stroke Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Acute Ischemic Stroke Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Acute Ischemic Stroke Pipeline on our website @ Acute Ischemic Stroke Emerging Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Acute Ischemic Stroke: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Acute Ischemic Stroke– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Enzastaurin: Denovo BioPharma
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. MDNA55: Medicenna Therapeutics, Inc.
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I/II)
  14. Zotiraciclib: Adastra Pharmaceuticals
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. RGN6024: Reglagene, Inc.
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Acute Ischemic Stroke Key Companies
  21. Acute Ischemic Stroke Key Products
  22. Acute Ischemic Stroke- Unmet Needs
  23. Acute Ischemic Stroke- Market Drivers and Barriers
  24. Acute Ischemic Stroke- Future Perspectives and Conclusion
  25. Acute Ischemic Stroke Analyst Views
  26. Acute Ischemic Stroke Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Acute Ischemic Stroke Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

CyberACE Unveils High-Rarity Card Buyback Plan, Opening New Opportunities for NFT Value Growth

CyberACE recently launched an innovative buyback program for high-rarity NFTs, specifically targeting SR, SSR, and UR card levels. This program aims to provide NFT holders with unprecedented value and long-term investment returns. By offering buybacks, CyberACE enables holders of these rare cards to achieve stable returns while increasing their market liquidity. Notably, SSR cards have a base buyback of 2,500 USDT, and UR cards offer an impressive 15,000 USDT, making these NFTs particularly attractive to investors.

As the NFT market continues to thrive, CyberACE’s card collection is increasingly recognized for its collectible and investment value. To further benefit holders, the platform’s buyback mechanism enhances these cards’ market fluidity, particularly for high-tier cards like SSR and UR. Beyond providing guaranteed buyback returns, the platform ensures each card’s retained value by incorporating the staking funds within each card. This approach significantly enhances the investment potential of CyberACE’s NFTs.

CyberACE’s initiatives extend beyond buybacks to actively introduce high-rarity cards to international auction markets, in collaboration with globally renowned auction houses. Through partnerships, UR cards and other rare NFTs gain visibility within high-end art markets, thus expanding their collection appeal and value potential. This strategy opens additional exit routes for holders, reinforcing CyberACE’s commitment to the NFT market’s growth and establishing a promising landscape for long-term NFT value appreciation.

The launch of the card buyback plan underscores CyberACE’s dedication to its community and exemplifies the platform’s confidence in the future of the NFT market. As CyberACE continues to innovate and expand its global presence, high-rarity cards are set to become coveted assets among worldwide investors. The platform’s ongoing developments aim to enrich user experiences and deliver more substantial value-creation opportunities within the digital asset ecosystem.

Looking forward, CyberACE remains committed to deepening its NFT expertise, merging digital art with investment, and creating an even more dynamic and innovative digital asset landscape.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: CyberAce
Contact Person: EdgarPlans
Email: Send Email
Country: HongKong
Website: https://www.cyberace66.org/#/